SMAD5 and colorectal carcinoma: revealed the potential mechanism by which inflammation-induced S100A8 could promote the development of CRC by activating the protein kinase B 1 (Akt1)-Smad family member 5 (Smad5)-inhibitor of DNA binding 3 (Id3) axis (40).